Pharma & Bio
Technology
FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Hopes for Follow-On Licensing [K-Bio Pulse]
On August 10, South Korean pharmaceutical and biotech stocks rose across the board as the KOSDAQ rebounded. FromBio soared to the daily upper limit as trading resumed following a 5-for-1 reverse stock…
Technology
From Bio Co., Ltd. Hits Daily Limit Up as Trading Resumes… curacle co., ltd. Also Surges on Expectations of ‘Follow-up Technology Transfer’ [Bio Spotlight]
On the 10th, domestic pharmaceutical and biotech stocks showed an overall upward trend, buoyed by a rebound in the KOSDAQ index. From Bio Co., Ltd.(377220), which resumed trading that day after comple…
Technology
Coreline Soft Co., Ltd. Brings AI to U.S. Hospital Reading Rooms… Expanding Commercial Workflow in North America
Coreline Soft Co., Ltd.(384470)has supplied medical artificial intelligence (AI) to a 651-bed regional academic medical center in the U.S. and began using it for actual patient diagnoses last month. T…
Lifestyle
Laseroptek Co., Ltd. CEO Lee Chang-jin: "Double-Digit Operating Profit Margin by 2027 with Bascula 589"
In the global market for laser medical devices used in dermatological aesthetics and treatment, South Korea’s first-generation solid-state laser venture, Laseroptek Co., Ltd.(199550), is leading a par…
Technology
[The Era of Oral Weight-Loss Drugs, Part 1] Following the U.S. and the EU, South Korea Is on the Verge of Launch… Key Issues Regarding Insurance Coverage and Prescriptions
The center of gravity in the obesity treatment market is shifting rapidly. As oral glucagon-like peptide-1 (GLP-1) drugs are being commercially launched one after another in the United States and the …
Technology
JointStem: Stalled in Korea but Rapidly Developed in the U.S.—Reasons Behind the Mixed Reactions
Regulatory authorities in South Korea and the United States have reached differing conclusions regarding “JointStem,” a stem cell therapy for degenerative knee osteoarthritis developed by NATURECELL C…
Lifestyle
'38 billion in Cash vs. 70 billion in Market Cap': Foreign Investors Buy EyeGene,Inc for 6th Consecutive Day... CEO Also Triples His Stake
Foreign investors are flocking to the new drug developer EyeGene,Inc(185490)as the perception that the company is undervalued continues to spread. Even as foreign investors sold off shares across the …
Lifestyle
Market Fluctuates; Daehwa Pharm, LabGenomics, and NeoImmuneTech Rise [K-Bio Pulse]
On the 7th, amid mixed trading in the South Korean stock market, pharmaceutical and biotech companies demonstrating clear earnings growth and solid momentum stood out. Departing from past trends that …
Lifestyle
Amid Mixed Market Conditions, DAE HWA PHARM CO., LTD., LabGenomics. Co., Ltd., and NeoImmuneTech, Inc. Rise [Bio Spotlight]
On the 7th, while the domestic stock market showed mixed trends, companies in the pharmaceutical and biotech sectors that demonstrated clear earnings growth and solid momentum stood out. Moving away f…
Lifestyle
D&D and Pfizer’s Momentum Remains Strong… The Key Lies in the Unannounced ‘MET-097o’
D&D Pharmatech’s stock price plummeted after Pfizer halted development of MET-224o, an oral obesity treatment candidate acquired through its acquisition of Metsera. However, it has been confirmed that…